chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pain in extremity, Pyrexia
Clinical narrative: Heart really hurts; Difficulty breathing; Pain in her chest; Sore arm; Body aches; Fever; Fatigue; Headache; This is a spontaneous report from a contactable consumer or other non-health care professional (parent). A 15-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0127 and expiration date was not reported), second dose via an unspecified route of administration, administered in arm left on 08Jun2021 17:45 (at the age of 15 years) as single for covid-19 immunisation. Medical history included vocal cord dysfunction, allergy to animal (cat), Low blood pressure issue, (Patient had to stay hydrated, or she can become faint when she stands up (it is a low blood pressure issue) (she has to stay hydrated or can become faint when she stands up) from an unknown date and unknown if ongoing. Concomitant medication included ibuprofen (ADVIL) taken for an unspecified indication, start and stop date were not reported and patient received within 2 weeks of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior vaccination and since the vaccination. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0173 02:30 PM and expiration date was not reported), first dose on 15May2021 as single for covid-19 immunisation. The patient experienced heart really hurts, difficulty breathing and Pain in her chest on 10Jun2021 03:00, sore arm, body aches, fever, fatigue and headache on 09Jun2021. Reported as Patient experienced many of the typical side effects like a sore arm, body aches, a fever, fatigue and a headache. Overnight from Wed to Thurs, patient woke up at about 3 AM with bad pain in her chest and difficulty breathing. In her words "my heart really hurts and it is hurts to breath." She was received one 500 mg Tylenol capsule (she had not had anything up to that point) along with Frankincense oil topically. patient was in too much pain to go back to sleep so she was up for about 2 hours but then she did finally fall back asleep. Her heart pain decreased during the day on Thursday and today she says it is not hurting. When father of patient heard about children (withheld) age experiencing myocarditis after the vaccine, he thought it sounded like what she experienced. Father of patient am concerned that there might be some kind of long-term damage to her heart. Therapeutic measures were taken as a result of heart really hurts, sore arm, body aches, fever, headache, pain in her chest, difficulty breathing and therapeutic measures not taken for Fatigue. The outcome for the event Heart really hurts was resolved on 11Jan2021 and other events was unknown.   Information on lot/batch number was available. Additional information has been requested.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Chest X-ray, Echocardiogram, Electrocardiogram, Pericarditis
Clinical narrative: Pericarditis; This is a spontaneous report from a contactable consumer (patient) reported that an 18-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0170), via an unspecified route of administration, administered in arm left on 21Apr2021 (at the age of 18-years-old) as dose 2, single for covid-19 immunization. The vaccine was administered at the Pharmacy/drugstore. The patient's medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8734), administered in arm left on 31Mar2021 (at the age of 18-years-old) as 1st dose for covid-19 immunization. The patient experienced pericarditis on 01May2021. Therapeutic measures were taken as a result of pericarditis as the patient received Advil for inflammation and follow-up on cardio. The event resulted in Emergency room/department or urgent care. The outcome of the event was unknown.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pericarditis
Clinical narrative: Pericarditis; This is a spontaneous report from a contactable consumer (patient) reported that an 18-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0170), via an unspecified route of administration, administered in arm left on 21Apr2021 (at the age of 18-years-old) as dose 2, single for covid-19 immunization. The vaccine was administered at the Pharmacy/drugstore. The patient's medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8734), administered in arm left on 31Mar2021 (at the age of 18-years-old) as 1st dose for covid-19 immunization. The patient experienced pericarditis on 01May2021. Therapeutic measures were taken as a result of pericarditis as the patient received Advil for inflammation and follow-up on cardio. The event resulted in Emergency room/department or urgent care. The outcome of the event was unknown.
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, Fatigue, Genital herpes, Genital lesion, Lymphadenopathy
Clinical narrative: Enflamed and swollen labia/Multiple genital laisons; Enflamed and swollen labia/Multiple genital laisons; Fever; fatigue; swollen lymph nodes; This is a spontaneous report from a contactable consumer (patient). A 15-year-old not pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left at age of 15-year-old, not pregnant on 04Jun2021 16:45 (Lot Number: EW0186) as single dose for covid-19 immunisation.  Medical history included Developmental absence seizures, epilepsy, Pineapple allergy. The patient's concomitant medications were none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No medications the patient received within 2 weeks of vaccination. The patient previous took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in arm left at age of 15-year-old on 14May2021 04:45PM (Lot Number: EW0183) as single dose for Covid-19 Immunization. On 06Jun2021 07:00 AM, the patient experienced fever, fatigue, swollen lymph node; multiple genital laisons determined NOT to be herpes; enflamed and swollen labia. Antiviral medication and steroid creams prescribed. Adverse events resulted in Doctor or other healthcare professional office/clinic visit. Not diagnosed COVID prior vaccination. COVID was not tested post vaccination. Seriousness was no. The outcome of the events was not recovered.
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Enflamed and swollen labia/Multiple genital laisons; Enflamed and swollen labia/Multiple genital laisons; Fever; fatigue; swollen lymph nodes; This is a spontaneous report from a contactable consumer (patient). A 15-year-old not pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left at age of 15-year-old, not pregnant on 04Jun2021 16:45 (Lot Number: EW0186) as single dose for covid-19 immunisation.  Medical history included Developmental absence seizures, epilepsy, Pineapple allergy. The patient's concomitant medications were none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No medications the patient received within 2 weeks of vaccination. The patient previous took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in arm left at age of 15-year-old on 14May2021 04:45PM (Lot Number: EW0183) as single dose for Covid-19 Immunization. On 06Jun2021 07:00 AM, the patient experienced fever, fatigue, swollen lymph node; multiple genital laisons determined NOT to be herpes; enflamed and swollen labia. Antiviral medication and steroid creams prescribed. Adverse events resulted in Doctor or other healthcare professional office/clinic visit. Not diagnosed COVID prior vaccination. COVID was not tested post vaccination. Seriousness was no. The outcome of the events was not recovered.
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Fatigue, Genital tract inflammation, Lymphadenopathy, Oedema genital, Pyrexia
Clinical narrative: Enflamed and swollen labia/Multiple genital laisons; Enflamed and swollen labia/Multiple genital laisons; Fever; fatigue; swollen lymph nodes; This is a spontaneous report from a contactable consumer (patient). A 15-year-old not pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left at age of 15-year-old, not pregnant on 04Jun2021 16:45 (Lot Number: EW0186) as single dose for covid-19 immunisation.  Medical history included Developmental absence seizures, epilepsy, Pineapple allergy. The patient's concomitant medications were none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No medications the patient received within 2 weeks of vaccination. The patient previous took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in arm left at age of 15-year-old on 14May2021 04:45PM (Lot Number: EW0183) as single dose for Covid-19 Immunization. On 06Jun2021 07:00 AM, the patient experienced fever, fatigue, swollen lymph node; multiple genital laisons determined NOT to be herpes; enflamed and swollen labia. Antiviral medication and steroid creams prescribed. Adverse events resulted in Doctor or other healthcare professional office/clinic visit. Not diagnosed COVID prior vaccination. COVID was not tested post vaccination. Seriousness was no. The outcome of the events was not recovered.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chest pain, Chills, Dyspnoea, Electrocardiogram
Clinical narrative: Myocarditis; breathing issues; chest pain; muscle aches; chills; left leg swelling; fatigue; This is a spontaneous report from a contactable consumer (Patient, self-reported). A 47-year-old non pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0177), dose 2 via an unspecified route of administration, administered in Arm Right on 18May2021 12:00 (at the age of 47-years-old) as dose 2, single for covid-19 immunisation. Medical history included High blood pressure, asthma, allergy to animal (allergies :Cats). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient did not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. Concomitant medications included lisinopril. Patient took 1st dose of bnt162b2 (Batch/Lot Number: Ew0175), administered in Arm Left on 22Apr2021 12:15 for covid-19 immunisation. On 19May2021 01:00, the patient experienced myocarditis, chest pain, muscle aches, chills, left leg swelling, breathing issues and fatigue. The event myocarditis was serious. Patient visited Doctor or other healthcare professional office/clinic visit for adverse events. No treatment received for adverse events. Outcome of the events was not recovered.  Information on Lot/Batch number was available. Additional information has been requested.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Heart rate increased, Inflammation, Pain
Clinical narrative: Myocarditis; breathing issues; chest pain; muscle aches; chills; left leg swelling; fatigue; This is a spontaneous report from a contactable consumer (Patient, self-reported). A 47-year-old non pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0177), dose 2 via an unspecified route of administration, administered in Arm Right on 18May2021 12:00 (at the age of 47-years-old) as dose 2, single for covid-19 immunisation. Medical history included High blood pressure, asthma, allergy to animal (allergies :Cats). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient did not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. Concomitant medications included lisinopril. Patient took 1st dose of bnt162b2 (Batch/Lot Number: Ew0175), administered in Arm Left on 22Apr2021 12:15 for covid-19 immunisation. On 19May2021 01:00, the patient experienced myocarditis, chest pain, muscle aches, chills, left leg swelling, breathing issues and fatigue. The event myocarditis was serious. Patient visited Doctor or other healthcare professional office/clinic visit for adverse events. No treatment received for adverse events. Outcome of the events was not recovered.  Information on Lot/Batch number was available. Additional information has been requested.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Chills, Dyspnoea, Fatigue, Myalgia
Clinical narrative: Myocarditis; breathing issues; chest pain; muscle aches; chills; left leg swelling; fatigue; This is a spontaneous report from a contactable consumer (Patient, self-reported). A 47-year-old non pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0177), dose 2 via an unspecified route of administration, administered in Arm Right on 18May2021 12:00 (at the age of 47-years-old) as dose 2, single for covid-19 immunisation. Medical history included High blood pressure, asthma, allergy to animal (allergies :Cats). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient did not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. Concomitant medications included lisinopril. Patient took 1st dose of bnt162b2 (Batch/Lot Number: Ew0175), administered in Arm Left on 22Apr2021 12:15 for covid-19 immunisation. On 19May2021 01:00, the patient experienced myocarditis, chest pain, muscle aches, chills, left leg swelling, breathing issues and fatigue. The event myocarditis was serious. Patient visited Doctor or other healthcare professional office/clinic visit for adverse events. No treatment received for adverse events. Outcome of the events was not recovered.  Information on Lot/Batch number was available. Additional information has been requested.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myocarditis, Peripheral swelling
Clinical narrative: Myocarditis; breathing issues; chest pain; muscle aches; chills; left leg swelling; fatigue; This is a spontaneous report from a contactable consumer (Patient, self-reported). A 47-year-old non pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0177), dose 2 via an unspecified route of administration, administered in Arm Right on 18May2021 12:00 (at the age of 47-years-old) as dose 2, single for covid-19 immunisation. Medical history included High blood pressure, asthma, allergy to animal (allergies :Cats). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient did not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. Concomitant medications included lisinopril. Patient took 1st dose of bnt162b2 (Batch/Lot Number: Ew0175), administered in Arm Left on 22Apr2021 12:15 for covid-19 immunisation. On 19May2021 01:00, the patient experienced myocarditis, chest pain, muscle aches, chills, left leg swelling, breathing issues and fatigue. The event myocarditis was serious. Patient visited Doctor or other healthcare professional office/clinic visit for adverse events. No treatment received for adverse events. Outcome of the events was not recovered.  Information on Lot/Batch number was available. Additional information has been requested.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test abnormal, Contusion, Epistaxis, Exposure during pregnancy, Full blood count abnormal
Clinical narrative: low platelets by blood test showing 30,000; Bruising all over body, fatigue, confirmed as low platelets by blood test showing 30,000... normal range is 150,000-440,000.  Could have been 20,000 or lower based on timing of blood test.; Bruising all over body, fatigue, confirmed as low platelets by blood test showing 30,000... normal range is 150,000-440,000.  Could have been 20,000 or lower based on timing of blood test.; Pregnant: Yes; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: EW0171 and Expire Date: unknown) via unspecified route of administration in left arm on 24Apr021 (age at the time of vaccination: 41) as 2nd dose, single for Covid-19 immunisation. Ethnicity information was available. The patient was pregnant at the time of vaccination and date was captured as some unspecified date in Apr2021. She took her first dose of vaccine (Batch/lot number-ER8732) via unspecified route of administration, in left arm on 02Apr2021 (age at the time of vaccination: 41) as single dose, for Covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was Public Health Clinic facility. Patient's medical history included endometriosis from an unspecified date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications the patient received within 2 weeks of vaccination was Pre-natal vitamins for unspecified indication. It has been reported that patient experienced bruising all over body, fatigue, confirmed as low platelets by blood test showing 30,000... normal range is 150,000-440,000 on 01May2021.  It could have been 20,000 or lower based on timing of blood test. Treatment was given for the adverse events and referred to Hematologist for evaluation. There was emergency room visit and Physician Office Visit due to the events. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. Patient had no known allergies. Device Date was given as 12Jun2021. The outcome of the events was recovering.   Information on Lot/Batch number was available. Additional information has been requested.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Gingival bleeding, Platelet count decreased, Red blood cell count decreased, Thrombocytopenia, White blood cell count normal
Clinical narrative: low platelets by blood test showing 30,000; Bruising all over body, fatigue, confirmed as low platelets by blood test showing 30,000... normal range is 150,000-440,000.  Could have been 20,000 or lower based on timing of blood test.; Bruising all over body, fatigue, confirmed as low platelets by blood test showing 30,000... normal range is 150,000-440,000.  Could have been 20,000 or lower based on timing of blood test.; Pregnant: Yes; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: EW0171 and Expire Date: unknown) via unspecified route of administration in left arm on 24Apr021 (age at the time of vaccination: 41) as 2nd dose, single for Covid-19 immunisation. Ethnicity information was available. The patient was pregnant at the time of vaccination and date was captured as some unspecified date in Apr2021. She took her first dose of vaccine (Batch/lot number-ER8732) via unspecified route of administration, in left arm on 02Apr2021 (age at the time of vaccination: 41) as single dose, for Covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was Public Health Clinic facility. Patient's medical history included endometriosis from an unspecified date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications the patient received within 2 weeks of vaccination was Pre-natal vitamins for unspecified indication. It has been reported that patient experienced bruising all over body, fatigue, confirmed as low platelets by blood test showing 30,000... normal range is 150,000-440,000 on 01May2021.  It could have been 20,000 or lower based on timing of blood test. Treatment was given for the adverse events and referred to Hematologist for evaluation. There was emergency room visit and Physician Office Visit due to the events. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. Patient had no known allergies. Device Date was given as 12Jun2021. The outcome of the events was recovering.   Information on Lot/Batch number was available. Additional information has been requested.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Contusion, Exposure during pregnancy, Fatigue, Platelet count decreased
Clinical narrative: low platelets by blood test showing 30,000; Bruising all over body, fatigue, confirmed as low platelets by blood test showing 30,000... normal range is 150,000-440,000.  Could have been 20,000 or lower based on timing of blood test.; Bruising all over body, fatigue, confirmed as low platelets by blood test showing 30,000... normal range is 150,000-440,000.  Could have been 20,000 or lower based on timing of blood test.; Pregnant: Yes; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: EW0171 and Expire Date: unknown) via unspecified route of administration in left arm on 24Apr021 (age at the time of vaccination: 41) as 2nd dose, single for Covid-19 immunisation. Ethnicity information was available. The patient was pregnant at the time of vaccination and date was captured as some unspecified date in Apr2021. She took her first dose of vaccine (Batch/lot number-ER8732) via unspecified route of administration, in left arm on 02Apr2021 (age at the time of vaccination: 41) as single dose, for Covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was Public Health Clinic facility. Patient's medical history included endometriosis from an unspecified date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications the patient received within 2 weeks of vaccination was Pre-natal vitamins for unspecified indication. It has been reported that patient experienced bruising all over body, fatigue, confirmed as low platelets by blood test showing 30,000... normal range is 150,000-440,000 on 01May2021.  It could have been 20,000 or lower based on timing of blood test. Treatment was given for the adverse events and referred to Hematologist for evaluation. There was emergency room visit and Physician Office Visit due to the events. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. Patient had no known allergies. Device Date was given as 12Jun2021. The outcome of the events was recovering.   Information on Lot/Batch number was available. Additional information has been requested.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arrhythmia, Blood test normal, Computerised tomogram normal, Cough, Dyspnoea
Clinical narrative: In the week following my vaccine, I started feeling a shortness of breath, a rapid/fluttery  heartbeat on occasion, and a heaviness in my chest. It had not resolved after a few weeks and my doctor sen; rapid fluttery heartbeat; heaviness in my chest; In the week following my vaccine, I started feeling a shortness of breath, a rapid/fluttery  heartbeat on occasion, and a heaviness in my chest. It had not resolved after a few weeks and my doctor sen; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 43-years-old non pregnant female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EW0164, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 23Apr2021 11:00 as DOSE 2, SINGLE for covid-19 immunization. Prior to the vaccination the patient was not diagnosed with COVID-19. Previously the patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EN6207, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 24Mar2021 11:00 as DOSE 1, SINGLE for covid-19 immunization. Since the vaccination the patient had not been diagnosed with COVID-19. Medical history included hypertension from an unknown date, restless legs syndrome from an unknown date, hypersensitivity from an unknown date (Environmental allergies as reported), and drug hypersensitivity (Sulfa allergy) from an unknown date. Concomitant medications included levocetirizine dihydrochloride (XYZAL) taken for an unspecified indication, from an unknown start date, propranolol (PROPRANOLOL) taken for an unspecified indication, from an unknown start date, ropinirole (ROPINIROLE) taken for an unspecified indication, from an unknown start date. On 28Apr2021 at 12:00, the patient reported that in the week following the vaccine the patient started feeling a shortness of breath, a rapid fluttery heartbeat on occasion, and a heaviness in my chest. It had not resolved after a few weeks and my doctor send me to the emergency room due to the timing of the symptoms and vaccine. On 28Apr2021, the patient also had blood test, computerised tomogram and electrocardiogram and results were unknown at the time of report. The patient was treated for the events due to which she was sent to emergency room and had to visit the doctor at times. The outcome of the events was reported as recovering at the time of report.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram normal, Heart rate increased, Palpitations
Clinical narrative: In the week following my vaccine, I started feeling a shortness of breath, a rapid/fluttery  heartbeat on occasion, and a heaviness in my chest. It had not resolved after a few weeks and my doctor sen; rapid fluttery heartbeat; heaviness in my chest; In the week following my vaccine, I started feeling a shortness of breath, a rapid/fluttery  heartbeat on occasion, and a heaviness in my chest. It had not resolved after a few weeks and my doctor sen; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 43-years-old non pregnant female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EW0164, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 23Apr2021 11:00 as DOSE 2, SINGLE for covid-19 immunization. Prior to the vaccination the patient was not diagnosed with COVID-19. Previously the patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EN6207, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 24Mar2021 11:00 as DOSE 1, SINGLE for covid-19 immunization. Since the vaccination the patient had not been diagnosed with COVID-19. Medical history included hypertension from an unknown date, restless legs syndrome from an unknown date, hypersensitivity from an unknown date (Environmental allergies as reported), and drug hypersensitivity (Sulfa allergy) from an unknown date. Concomitant medications included levocetirizine dihydrochloride (XYZAL) taken for an unspecified indication, from an unknown start date, propranolol (PROPRANOLOL) taken for an unspecified indication, from an unknown start date, ropinirole (ROPINIROLE) taken for an unspecified indication, from an unknown start date. On 28Apr2021 at 12:00, the patient reported that in the week following the vaccine the patient started feeling a shortness of breath, a rapid fluttery heartbeat on occasion, and a heaviness in my chest. It had not resolved after a few weeks and my doctor send me to the emergency room due to the timing of the symptoms and vaccine. On 28Apr2021, the patient also had blood test, computerised tomogram and electrocardiogram and results were unknown at the time of report. The patient was treated for the events due to which she was sent to emergency room and had to visit the doctor at times. The outcome of the events was reported as recovering at the time of report.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Atrial flutter, Blood test, Chest discomfort, Computerised tomogram, Dyspnoea
Clinical narrative: In the week following my vaccine, I started feeling a shortness of breath, a rapid/fluttery  heartbeat on occasion, and a heaviness in my chest. It had not resolved after a few weeks and my doctor sen; rapid fluttery heartbeat; heaviness in my chest; In the week following my vaccine, I started feeling a shortness of breath, a rapid/fluttery  heartbeat on occasion, and a heaviness in my chest. It had not resolved after a few weeks and my doctor sen; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 43-years-old non pregnant female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EW0164, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 23Apr2021 11:00 as DOSE 2, SINGLE for covid-19 immunization. Prior to the vaccination the patient was not diagnosed with COVID-19. Previously the patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EN6207, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 24Mar2021 11:00 as DOSE 1, SINGLE for covid-19 immunization. Since the vaccination the patient had not been diagnosed with COVID-19. Medical history included hypertension from an unknown date, restless legs syndrome from an unknown date, hypersensitivity from an unknown date (Environmental allergies as reported), and drug hypersensitivity (Sulfa allergy) from an unknown date. Concomitant medications included levocetirizine dihydrochloride (XYZAL) taken for an unspecified indication, from an unknown start date, propranolol (PROPRANOLOL) taken for an unspecified indication, from an unknown start date, ropinirole (ROPINIROLE) taken for an unspecified indication, from an unknown start date. On 28Apr2021 at 12:00, the patient reported that in the week following the vaccine the patient started feeling a shortness of breath, a rapid fluttery heartbeat on occasion, and a heaviness in my chest. It had not resolved after a few weeks and my doctor send me to the emergency room due to the timing of the symptoms and vaccine. On 28Apr2021, the patient also had blood test, computerised tomogram and electrocardiogram and results were unknown at the time of report. The patient was treated for the events due to which she was sent to emergency room and had to visit the doctor at times. The outcome of the events was reported as recovering at the time of report.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram, Heart rate increased
Clinical narrative: In the week following my vaccine, I started feeling a shortness of breath, a rapid/fluttery  heartbeat on occasion, and a heaviness in my chest. It had not resolved after a few weeks and my doctor sen; rapid fluttery heartbeat; heaviness in my chest; In the week following my vaccine, I started feeling a shortness of breath, a rapid/fluttery  heartbeat on occasion, and a heaviness in my chest. It had not resolved after a few weeks and my doctor sen; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 43-years-old non pregnant female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EW0164, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 23Apr2021 11:00 as DOSE 2, SINGLE for covid-19 immunization. Prior to the vaccination the patient was not diagnosed with COVID-19. Previously the patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EN6207, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 24Mar2021 11:00 as DOSE 1, SINGLE for covid-19 immunization. Since the vaccination the patient had not been diagnosed with COVID-19. Medical history included hypertension from an unknown date, restless legs syndrome from an unknown date, hypersensitivity from an unknown date (Environmental allergies as reported), and drug hypersensitivity (Sulfa allergy) from an unknown date. Concomitant medications included levocetirizine dihydrochloride (XYZAL) taken for an unspecified indication, from an unknown start date, propranolol (PROPRANOLOL) taken for an unspecified indication, from an unknown start date, ropinirole (ROPINIROLE) taken for an unspecified indication, from an unknown start date. On 28Apr2021 at 12:00, the patient reported that in the week following the vaccine the patient started feeling a shortness of breath, a rapid fluttery heartbeat on occasion, and a heaviness in my chest. It had not resolved after a few weeks and my doctor send me to the emergency room due to the timing of the symptoms and vaccine. On 28Apr2021, the patient also had blood test, computerised tomogram and electrocardiogram and results were unknown at the time of report. The patient was treated for the events due to which she was sent to emergency room and had to visit the doctor at times. The outcome of the events was reported as recovering at the time of report.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Blood test, Diplopia, Disturbance in attention, Dizziness
Clinical narrative: Immediate reaction of arms tingling; Nausea; Vomiting; Headache; Fever; Fatigue; Shortness of breath; Head pressure; Double vision; Cannot concentrate for any length of time; Dizziness; Unsteadiness; This is a spontaneous report from a contactable consumer or other non hcp. This consumer (patient) reported for himself that a 25-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: EW0171), dose 1 via an unspecified route of administration, administered in Arm Right on 02May2021 12:00 (Age at vaccination: 25) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included seasonal allergy. The patient's concomitant medications were not reported. The patient previously took erythromycin and sulfa. On 02May2021 12:00, the patient experienced Immediate reaction of arms tingling; Nausea; Vomiting; Headache; Fever; Fatigue; Shortness of breath; Head pressure; Double vision; Cannot concentrate for any length of time; Dizziness and Unsteadiness . Patient was received steroids as treatment for events. No hospitalization prolonged. The patient underwent lab tests and procedures which included blood test: normal on, electrocardiogram: normal on, magnetic resonance imaging: normal on, sars-cov-2 test: negative on 06May2021, sars-cov-2 test: negative on 19May2021. It was reported that patient had basic vaccine symptoms the first week including headache, nausea, fever. After a week, COVID fog/fatigue symptoms began. It is currently 6 weeks later and patient had fatigue, shortness of breath, head pressure, double vision, cannot concentrate for any length of time and dizziness/unsteadiness. I have not been able to go to work since the vaccine and have people helping take care of me. I cannot take a shower without being short of breath. I have been put on 2 different rounds of steroids - the 2nd more aggressive, which did not make a difference. I have been to my general doctor several times, an allergist and a neurologist. I had no previous health problems. Symptoms had not improved in the past 3-4 weeks. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been not tested for COVID-19. The clinical outcome of all events were not recovered.  Follow-up attempts are needed. Further information is requested.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Electrocardiogram normal, Fatigue, Feeling abnormal, Head discomfort
Clinical narrative: Immediate reaction of arms tingling; Nausea; Vomiting; Headache; Fever; Fatigue; Shortness of breath; Head pressure; Double vision; Cannot concentrate for any length of time; Dizziness; Unsteadiness; This is a spontaneous report from a contactable consumer or other non hcp. This consumer (patient) reported for himself that a 25-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: EW0171), dose 1 via an unspecified route of administration, administered in Arm Right on 02May2021 12:00 (Age at vaccination: 25) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included seasonal allergy. The patient's concomitant medications were not reported. The patient previously took erythromycin and sulfa. On 02May2021 12:00, the patient experienced Immediate reaction of arms tingling; Nausea; Vomiting; Headache; Fever; Fatigue; Shortness of breath; Head pressure; Double vision; Cannot concentrate for any length of time; Dizziness and Unsteadiness . Patient was received steroids as treatment for events. No hospitalization prolonged. The patient underwent lab tests and procedures which included blood test: normal on, electrocardiogram: normal on, magnetic resonance imaging: normal on, sars-cov-2 test: negative on 06May2021, sars-cov-2 test: negative on 19May2021. It was reported that patient had basic vaccine symptoms the first week including headache, nausea, fever. After a week, COVID fog/fatigue symptoms began. It is currently 6 weeks later and patient had fatigue, shortness of breath, head pressure, double vision, cannot concentrate for any length of time and dizziness/unsteadiness. I have not been able to go to work since the vaccine and have people helping take care of me. I cannot take a shower without being short of breath. I have been put on 2 different rounds of steroids - the 2nd more aggressive, which did not make a difference. I have been to my general doctor several times, an allergist and a neurologist. I had no previous health problems. Symptoms had not improved in the past 3-4 weeks. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been not tested for COVID-19. The clinical outcome of all events were not recovered.  Follow-up attempts are needed. Further information is requested.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Hepatic enzyme increased, Immediate post-injection reaction, Impaired work ability, Magnetic resonance imaging normal
Clinical narrative: Immediate reaction of arms tingling; Nausea; Vomiting; Headache; Fever; Fatigue; Shortness of breath; Head pressure; Double vision; Cannot concentrate for any length of time; Dizziness; Unsteadiness; This is a spontaneous report from a contactable consumer or other non hcp. This consumer (patient) reported for himself that a 25-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: EW0171), dose 1 via an unspecified route of administration, administered in Arm Right on 02May2021 12:00 (Age at vaccination: 25) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included seasonal allergy. The patient's concomitant medications were not reported. The patient previously took erythromycin and sulfa. On 02May2021 12:00, the patient experienced Immediate reaction of arms tingling; Nausea; Vomiting; Headache; Fever; Fatigue; Shortness of breath; Head pressure; Double vision; Cannot concentrate for any length of time; Dizziness and Unsteadiness . Patient was received steroids as treatment for events. No hospitalization prolonged. The patient underwent lab tests and procedures which included blood test: normal on, electrocardiogram: normal on, magnetic resonance imaging: normal on, sars-cov-2 test: negative on 06May2021, sars-cov-2 test: negative on 19May2021. It was reported that patient had basic vaccine symptoms the first week including headache, nausea, fever. After a week, COVID fog/fatigue symptoms began. It is currently 6 weeks later and patient had fatigue, shortness of breath, head pressure, double vision, cannot concentrate for any length of time and dizziness/unsteadiness. I have not been able to go to work since the vaccine and have people helping take care of me. I cannot take a shower without being short of breath. I have been put on 2 different rounds of steroids - the 2nd more aggressive, which did not make a difference. I have been to my general doctor several times, an allergist and a neurologist. I had no previous health problems. Symptoms had not improved in the past 3-4 weeks. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been not tested for COVID-19. The clinical outcome of all events were not recovered.  Follow-up attempts are needed. Further information is requested.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nausea, Paraesthesia, Pyrexia, Vomiting
Clinical narrative: Immediate reaction of arms tingling; Nausea; Vomiting; Headache; Fever; Fatigue; Shortness of breath; Head pressure; Double vision; Cannot concentrate for any length of time; Dizziness; Unsteadiness; This is a spontaneous report from a contactable consumer or other non hcp. This consumer (patient) reported for himself that a 25-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: EW0171), dose 1 via an unspecified route of administration, administered in Arm Right on 02May2021 12:00 (Age at vaccination: 25) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included seasonal allergy. The patient's concomitant medications were not reported. The patient previously took erythromycin and sulfa. On 02May2021 12:00, the patient experienced Immediate reaction of arms tingling; Nausea; Vomiting; Headache; Fever; Fatigue; Shortness of breath; Head pressure; Double vision; Cannot concentrate for any length of time; Dizziness and Unsteadiness . Patient was received steroids as treatment for events. No hospitalization prolonged. The patient underwent lab tests and procedures which included blood test: normal on, electrocardiogram: normal on, magnetic resonance imaging: normal on, sars-cov-2 test: negative on 06May2021, sars-cov-2 test: negative on 19May2021. It was reported that patient had basic vaccine symptoms the first week including headache, nausea, fever. After a week, COVID fog/fatigue symptoms began. It is currently 6 weeks later and patient had fatigue, shortness of breath, head pressure, double vision, cannot concentrate for any length of time and dizziness/unsteadiness. I have not been able to go to work since the vaccine and have people helping take care of me. I cannot take a shower without being short of breath. I have been put on 2 different rounds of steroids - the 2nd more aggressive, which did not make a difference. I have been to my general doctor several times, an allergist and a neurologist. I had no previous health problems. Symptoms had not improved in the past 3-4 weeks. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been not tested for COVID-19. The clinical outcome of all events were not recovered.  Follow-up attempts are needed. Further information is requested.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Blood test, Diplopia, Dizziness, Dyspnoea
Clinical narrative: Immediate reaction of arms tingling; Nausea; Vomiting; Headache; Fever; Fatigue; Shortness of breath; Head pressure; Double vision; Cannot concentrate for any length of time; Dizziness; Unsteadiness; This is a spontaneous report from a contactable consumer or other non hcp. This consumer (patient) reported for himself that a 25-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: EW0171), dose 1 via an unspecified route of administration, administered in Arm Right on 02May2021 12:00 (Age at vaccination: 25) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included seasonal allergy. The patient's concomitant medications were not reported. The patient previously took erythromycin and sulfa. On 02May2021 12:00, the patient experienced Immediate reaction of arms tingling; Nausea; Vomiting; Headache; Fever; Fatigue; Shortness of breath; Head pressure; Double vision; Cannot concentrate for any length of time; Dizziness and Unsteadiness . Patient was received steroids as treatment for events. No hospitalization prolonged. The patient underwent lab tests and procedures which included blood test: normal on, electrocardiogram: normal on, magnetic resonance imaging: normal on, sars-cov-2 test: negative on 06May2021, sars-cov-2 test: negative on 19May2021. It was reported that patient had basic vaccine symptoms the first week including headache, nausea, fever. After a week, COVID fog/fatigue symptoms began. It is currently 6 weeks later and patient had fatigue, shortness of breath, head pressure, double vision, cannot concentrate for any length of time and dizziness/unsteadiness. I have not been able to go to work since the vaccine and have people helping take care of me. I cannot take a shower without being short of breath. I have been put on 2 different rounds of steroids - the 2nd more aggressive, which did not make a difference. I have been to my general doctor several times, an allergist and a neurologist. I had no previous health problems. Symptoms had not improved in the past 3-4 weeks. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been not tested for COVID-19. The clinical outcome of all events were not recovered.  Follow-up attempts are needed. Further information is requested.